APA

Kurre H. A., Ettinger A. G., Veenstra D. L., Gaynon P. S., Franklin J., Sencer S. F., Reaman G. H., Lange B. J. & Holcenberg J. S. (20020523). A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962). : Journal of pediatric hematology/oncology.

Chicago

Kurre Helen A, Ettinger Alice G, Veenstra David L, Gaynon Paul S, Franklin Janet, Sencer Susan F, Reaman Gregory H, Lange Beverly J and Holcenberg John S. 20020523. A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962). : Journal of pediatric hematology/oncology.

Harvard

Kurre H. A., Ettinger A. G., Veenstra D. L., Gaynon P. S., Franklin J., Sencer S. F., Reaman G. H., Lange B. J. and Holcenberg J. S. (20020523). A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962). : Journal of pediatric hematology/oncology.

MLA

Kurre Helen A, Ettinger Alice G, Veenstra David L, Gaynon Paul S, Franklin Janet, Sencer Susan F, Reaman Gregory H, Lange Beverly J and Holcenberg John S. A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962). : Journal of pediatric hematology/oncology. 20020523.